These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14737849)

  • 21. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Involvement of Rho-kinase in hypertensive vascular disease--a novel therapeutic target in hypertension].
    Mukai Y
    Fukuoka Igaku Zasshi; 2002 Aug; 93(8):129-34. PubMed ID: 12382411
    [No Abstract]   [Full Text] [Related]  

  • 23. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
    Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
    J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rho-kinase, a potential therapeutic target for the treatment of hypertension.
    Hirooka Y; Shimokawa H; Takeshita A
    Drug News Perspect; 2004 Oct; 17(8):523-7. PubMed ID: 15605112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation ].
    Cosentino F
    Recenti Prog Med; 2003 Oct; 94(10):444-50. PubMed ID: 14619192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rho-kinase inhibitors for ischemic heart disease].
    Mohri M; Shimokawa H
    Nihon Rinsho; 2003 May; 61 Suppl 5():874-9. PubMed ID: 12809048
    [No Abstract]   [Full Text] [Related]  

  • 27. Rho-kinase inhibition in the therapy of cardiovascular disease.
    Lai A; Frishman WH
    Cardiol Rev; 2005; 13(6):285-92. PubMed ID: 16230885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho-kinase inhibitors show promise in pulmonary hypertension.
    Doggrell SA
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1157-9. PubMed ID: 16144499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROCKs as therapeutic targets in cardiovascular diseases.
    Rikitake Y; Liao JK
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure-independent effects of Rho-kinase inhibitors in the kidney?
    Jan Danser AH
    J Hypertens; 2004 Sep; 22(9):1675-7. PubMed ID: 15311093
    [No Abstract]   [Full Text] [Related]  

  • 31. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.
    Mukai Y; Shimokawa H; Matoba T; Kandabashi T; Satoh S; Hiroki J; Kaibuchi K; Takeshita A
    FASEB J; 2001 Apr; 15(6):1062-4. PubMed ID: 11292668
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasingly selective pharmacologic targets in cardiovascular disease.
    Paoletti R; Cignarella A
    Curr Atheroscler Rep; 2007 Aug; 9(2):89-90. PubMed ID: 17877914
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary hypertension.
    McLoughlin P; Hyvelin JM; Howell K
    N Engl J Med; 2005 Jan; 352(4):418-9; author reply 418-9. PubMed ID: 15673812
    [No Abstract]   [Full Text] [Related]  

  • 34. Rho guanosine triphosphatases in lung development and pulmonary hypertension.
    Kaufman J; Sakao E; Oka M; Nagaoka T; Oliver-Picket CK; Jones PL; McMurtry IF; Gebb SA
    Chest; 2005 Dec; 128(6 Suppl):610S. PubMed ID: 16373862
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel mechanisms contributing to cerebral vascular dysfunction during chronic hypertension.
    Sobey CG; Faraci FM
    Curr Hypertens Rep; 2001 Dec; 3(6):517-23. PubMed ID: 11734099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current state and perspective of studies on hypertensive complications].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2004 Jan; 62(1):7-13. PubMed ID: 14737829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho kinase inhibition on renal remodeling in an apatinib-induced hypertensive rat model.
    Li C; Wang Q; Qing Y; Ma L; Wang W; Chen J; Yu J
    J Hypertens; 2022 Sep; 40(9):1838-1840. PubMed ID: 35943108
    [No Abstract]   [Full Text] [Related]  

  • 38. Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more.
    Calò LA; Stefanelli LF; Bertoldi G; Ravarotto V
    J Hypertens; 2022 Sep; 40(9):1836-1837. PubMed ID: 35943107
    [No Abstract]   [Full Text] [Related]  

  • 39. A low protein diet to target cardiovascular disease and cancer in one shot?
    Meli AC
    Cardiovasc Res; 2019 Jan; 115(1):e1-e2. PubMed ID: 30576436
    [No Abstract]   [Full Text] [Related]  

  • 40. Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more.
    Abdel-Magid AF
    ACS Med Chem Lett; 2015 Apr; 6(4):371-2. PubMed ID: 25941551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.